NYSE:PEAK - Healthpeak Properties Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $32.79
  • Forecasted Upside: -3.10 %
  • Number of Analysts: 14
  • Breakdown:
  • 1 Sell Ratings
  • 5 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$33.84
▲ +0.75 (2.27%)

This chart shows the closing price for PEAK by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Healthpeak Properties Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PEAK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PEAK

Analyst Price Target is $32.79
▼ -3.10% Downside Potential
This price target is based on 14 analysts offering 12 month price targets for Healthpeak Properties in the last 3 months. The average price target is $32.79, with a high forecast of $39.00 and a low forecast of $28.00. The average price target represents a -3.10% upside from the last price of $33.84.

This chart shows the closing price for PEAK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 14 contributing investment analysts is to buy stock in Healthpeak Properties. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/29/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 1 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 1 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 1 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 1 sell ratings
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/15/2021ArgusBoost Price TargetBuy$34.00 ➝ $39.00Medium
5/26/2021JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$33.00 ➝ $34.00Medium
5/24/2021Royal Bank of CanadaBoost Price TargetOutperform$35.00 ➝ $36.00Medium
5/20/2021Berenberg BankUpgradeHold ➝ BuyLow
5/20/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$33.00 ➝ $34.00Low
5/6/2021BarclaysBoost Price TargetOverweight$33.00 ➝ $36.00Medium
4/14/2021Wells Fargo & CompanyBoost Price Target$25.00 ➝ $32.00Medium
3/30/2021Bank of AmericaUpgradeNeutral ➝ Buy$34.00 ➝ $35.50Low
3/15/2021Morgan StanleyBoost Price TargetEqual Weight$29.00 ➝ $30.00Medium
2/9/2021MizuhoBoost Price TargetNeutral$29.00 ➝ $32.00Low
1/20/2021Capital One FinancialUpgradeEqual Weight ➝ OverweightMedium
12/29/2020BarclaysBoost Price TargetOverweight$30.00 ➝ $33.00N/A
12/15/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target$28.00 ➝ $30.00Medium
12/15/2020Smith Barney CitigroupBoost Price Target$28.00 ➝ $30.00Medium
12/14/2020KeyCorpDowngradeOverweight ➝ Sector WeightLow
12/10/2020Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$26.00 ➝ $25.00High
11/4/2020Raymond JamesReiterated RatingBuyLow
10/16/2020MizuhoDowngradeBuy ➝ Neutral$30.00 ➝ $29.00Medium
9/4/2020BarclaysBoost Price TargetOverweight$28.00 ➝ $30.00Low
9/1/2020Stifel NicolausInitiated CoverageBuy$31.00High
8/21/2020Morgan StanleyBoost Price TargetEqual Weight$28.00 ➝ $29.00Low
7/2/2020CitigroupBoost Price TargetNeutral$24.00 ➝ $28.00Low
7/2/2020Berenberg BankInitiated CoverageHoldLow
5/22/2020BMO Capital MarketsReiterated RatingBuy$30.00Low
5/14/2020Royal Bank of CanadaLower Price Target$32.00 ➝ $27.00High
4/29/2020Raymond JamesDowngradeOutperform ➝ Market PerformHigh
4/21/2020MizuhoLower Price TargetBuy$41.00 ➝ $30.00Low
4/21/2020KeyCorpLower Price TargetOverweight$37.00 ➝ $30.00High
4/14/2020Royal Bank of CanadaReiterated RatingBuy$32.00Low
4/8/2020BarclaysReiterated RatingBuy$28.00High
4/7/2020CitigroupLower Price TargetNeutral$38.00 ➝ $24.00High
4/3/2020JPMorgan Chase & Co.Lower Price TargetOverweight$38.00 ➝ $29.00Medium
3/27/2020Wells Fargo & CompanyLower Price TargetEqual Weight$35.00 ➝ $26.00Medium
3/25/2020Raymond JamesLower Price TargetOutperform$37.00 ➝ $28.00High
3/23/2020Bank of AmericaDowngradeBuy ➝ NeutralHigh
3/17/2020Morgan StanleyLower Price TargetEqual Weight$35.00 ➝ $28.00High
3/9/2020Royal Bank of CanadaReiterated RatingBuy$40.00Medium
2/13/2020BMO Capital MarketsReiterated RatingBuy$38.00High
2/12/2020MizuhoReiterated RatingBuy$38.00High
12/19/2019MizuhoInitiated CoverageBuy$39.00High
(Data available from 6/21/2016 forward)
Healthpeak Properties logo
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
Read More

Today's Range

Now: $33.84
Low: $33.11
High: $34.00

50 Day Range

MA: $33.65
Low: $32.11
High: $35.30

52 Week Range

Now: $33.84
Low: $25.13
High: $35.31

Volume

2,653,171 shs

Average Volume

3,419,381 shs

Market Capitalization

$18.24 billion

P/E Ratio

66.35

Dividend Yield

3.63%

Beta

0.7

Frequently Asked Questions

What sell-side analysts currently cover shares of Healthpeak Properties?

The following equities research analysts have issued stock ratings on Healthpeak Properties in the last twelve months: Argus, Bank of America Co., Barclays PLC, Berenberg Bank, Capital One Financial Co., Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Raymond James, Royal Bank of Canada, Smith Barney Citigroup, Stifel Nicolaus, and Wells Fargo & Company.
View the latest analyst ratings for PEAK.

What is the current price target for Healthpeak Properties?

12 Wall Street analysts have set twelve-month price targets for Healthpeak Properties in the last year. Their average twelve-month price target is $32.79, suggesting a possible downside of 0.9%. Argus has the highest price target set, predicting PEAK will reach $39.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $28.00 for Healthpeak Properties in the next year.
View the latest price targets for PEAK.

What is the current consensus analyst rating for Healthpeak Properties?

Healthpeak Properties currently has 1 sell rating, 5 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PEAK will outperform the market and that investors should add to their positions of Healthpeak Properties.
View the latest ratings for PEAK.

What other companies compete with Healthpeak Properties?

How do I contact Healthpeak Properties' investor relations team?

Healthpeak Properties' physical mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The company's listed phone number is 949-407-0700 and its investor relations email address is [email protected] The official website for Healthpeak Properties is www.healthpeak.com.